Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
2.685
+0.015 (0.56%)
May 20, 2026, 9:36 AM EDT - Market open
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $248.82 million as of May 20, 2026. Its market cap has decreased by -67.17% in one year.
Market Cap
248.82M
Enterprise Value
115.68M
1-Year Change
-67.17%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has decreased from $284.60M to $248.82M, a decrease of -12.57%. That is a compound annual growth rate of -1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 247.40M | -22.23% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 272.52M |
| Inhibikase Therapeutics | 267.56M |
| ALX Oncology Holdings | 263.74M |
| Compugen | 258.13M |
| Zentalis Pharmaceuticals | 252.00M |
| SAB Biotherapeutics | 249.48M |
| Protara Therapeutics | 243.93M |
| Editas Medicine | 240.85M |